NCT04491617View on ClinicalTrials.gov

STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Postoperative PainOpioid UseProlapse; FemaleIncontinence
Interventions
OTHER

Standard opioid prescribing

Patients are routinely prescribed opioid medications in addition to non-opioids.

OTHER

Restrictive opioid prescribing

Patients are prescribed non-opioid pain medications, and will be prescribed opioids only if they request them.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT04491617 - STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial | Biotech Hunter | Biotech Hunter